May 2025, Volume 2, No. 5
Table of Contents

Letter from the Editors

Need fresh inspiration for your medtech company as we navigate Q225? We’ve gathered insights from some of our LSI alumni thought leaders to help you stay ahead.

Celebrating recent leadership shifts and other announcements and accolades impacting our global medtech community.

Big deals, even bigger questions. Jonathan Norris of HSBC Innovation Banking explains why 2025 is already one for the books.

Select Medtech Industry Financings & Deals March 2025, by Date Announced

Lisa Earnhardt, EVP and Group President of Medical Devices at Abbott, leads nearly $20 billion in global businesses with a vision shaped by startup grit and fueled by customer focus, patient outcomes, and bold collaboration. From cardiovascular disease to diabetes, Abbott’s goal is to democratize healthcare by staying grounded in what matters most.

Once limited to traditional surgical interventions, the market for rotator cuff repair suture anchors is now evolving, driven by an aging global population and advances in minimally invasive surgical techniques. As the demand for rotator cuff repair procedures steadily increases, suture anchors are becoming a cornerstone in restoring function and mobility to millions suffering from rotator cuff injuries. With ongoing innovations and competitive pressures, the market is set to see modest growth in the coming years.

The global drug delivery devices market is experiencing steady growth as innovations in biologics, smart technologies, and patient-centric design transform how treatments are administered across healthcare settings. From infusion systems and insulin pumps to wearable solutions, these devices are playing an increasingly vital role in managing chronic conditions and enhancing care.

Every week, LSI’s Market Intelligence team dives into a different topic shaping the future of medical technology. From disruptive startups to fast-growing device segments, we connect the dots between clinical demand, market dynamics, and innovation pipelines. Here’s what the LSI Market Intelligence team tracked this past month across electrophysiology (EP), transcatheter mitral valve replacement (TMVR), and the U.S. and APAC medtech markets.

This month, to accompany our Innovator Spotlight on Fluid Biomed, we detail the latest LSI Market Intelligence data on the global, Asian, European, and U.S. forecast volume for select neurovascular stroke procedures.

Backed by a 100% success rate in its first-in-human trial, an oversubscribed funding round, and a game-changing image-guided platform for airway management, Spiro Robotics is redefining how clinicians approach difficult intubations. CEO Dimitri Sokolov shares how engineering precision, clinical validation, and a clear path to FDA clearance are positioning the company to transform emergency and surgical care.

Inside John Wong, MD and team’s expectation-defying journey with their startup’s bioabsorbable brain stent technology, that has the worthy aim of reimagining how brain aneurysms are treated.

Celebrating the accomplishments of a few of the many bright stars in our LSI presenting company and speaker alumni community.

This month we’re showcasing technologies and organizations impacting our industry, and patient lives.

Trusted By The Companies Pioneering What’s Next

Work with us
Accelerate your business
We’re here to help you make smarter decisions and form stronger
partnerships through curated events, independent market intelligence
products and services, and digital-forward media.